STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] INCYTE CORP SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filing for INCY by named seller Barry Flannelly. The filer notifies a proposed sale of 17,447 common shares valued at $1,487,531.22 to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate sale date of 09/18/2025. The shares were acquired on 09/18/2025 by stock option exercise from the issuer and payment was made in cash the same day. The filing also lists five prior Common share sales by Barry Flannelly during July–August 2025 totaling 101,435 shares for gross proceeds of $8,631,432.53. The notice includes the required attestation about possession of material non-public information.

Positive
  • Clear compliance disclosure with broker, share counts, acquisition method, and aggregate market value
  • Transaction details specify acquisition by stock option exercise and same-day cash payment, which clarifies the origin of the shares
Negative
  • Material insider selling activity disclosed: 101,435 shares sold in July–August 2025 for gross proceeds of $8,631,432.53
  • Proposed additional sale of 17,447 shares ($1,487,531.22) increases total insider dispositions in the recent period

Insights

TL;DR: Insider filed a Rule 144 notice for a same-day exercise and planned sale of 17,447 shares through Morgan Stanley.

This Form 144 documents a proposed sale consistent with Rule 144 mechanics: acquisition by stock option exercise and planned disposition through a broker on the NASDAQ. The filing provides clear transaction timing, broker details, and aggregate market value, supporting compliance with Section 16/Rule 144 disclosure requirements. The presence of multiple recent sales by the same individual is disclosed, with precise shares sold and gross proceeds reported, which is important for trading transparency and monitoring potential insider disposition activity.

TL;DR: The transaction is quantified and routed through a major broker; impact appears procedural rather than transformative.

The filing quantifies the proposed sale at $1,487,531.22 and lists the broker as Morgan Stanley Smith Barney LLC, indicating a standard institutional execution channel. The shares were acquired and paid for on the same date via option exercise, which typically precedes insider sales to cover exercise costs or tax obligations. The disclosed prior sales total 101,435 shares with gross proceeds of $8,631,432.53, providing investors factual data to assess recent insider selling volume. From an ECM perspective, the filing is operational rather than a corporate-capital event.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does INCY Form 144 filed by Barry Flannelly report?

The filing reports a proposed sale of 17,447 common shares valued at $1,487,531.22, to be sold via Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 09/18/2025.

How were the 17,447 shares acquired according to the Form 144?

The shares were acquired on 09/18/2025 by stock option exercise from the issuer and payment was made in cash on that date.

What recent insider sales by Barry Flannelly are disclosed in the filing?

Five prior sales between 07/03/2025 and 08/13/2025 totaling 101,435 shares for gross proceeds of $8,631,432.53 are listed.

Which broker will handle the proposed sale listed in the INCY Form 144?

Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004 is named as the broker.

On which exchange is the proposed sale expected to occur?

The filing specifies NASDAQ as the securities exchange for the proposed sale.
Incyte Corp

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

19.98B
191.97M
2.03%
103.47%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON